ASCO News
Most Popular ASCO Story
ASCO hightlights Herceptin, PARP inhibitors
There's no shortage of cancer news this morning, thanks to the annual ASCO meeting. One drug that's getting a lot of press is Roche's blockbuster breast cancer biologic Herceptin. In patients with Read more...
Latest Headlines
- June 8, 2011
- June 7, 2011
- June 6, 2011
- June 2, 2009
- June 1, 2009
- May 29, 2009
- May 15, 2009
- January 15, 2009
- June 3, 2008
- June 2, 2008
- May 30, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
